Sign up
Quantellect · Congress · Trade Detail
NASDAQ: GILDGilead Sciences Inc
RepublicanSenate

John Boozman bought Gilead Sciences Inc (NASDAQ: GILD)

John Boozman (R-AR), a U.S. Senator, has disclosed 4 trades in Gilead Sciences Inc (GILD) since 2015, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: John Boozman bought $1,001 - $15,000 of Gilead Sciences Inc (NASDAQ: GILD) on April 24, 2015. Since that trade, GILD is up +85.28% against the S&P 500 up +314.34%, an outperformance of -229.06%.

Across these filings, John Boozman has been a balanced trader of GILD (a buy-to-sell ratio of 1.00). The most recent disclosed GILD transaction shown was dated April 16, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

GILD trades
4
Disclosed Vol
$32K
Buys
2
50%
Sells
2
50%
Buy / Sell
1.00
ratio
First → Last
2015–2025

John Boozman's GILD trades vs the price

GILD is up +85.28% since John Boozman bought on April 24, 2015, versus +314.34% for the S&P 500.

Performance since this trade

Price change since trade
+85.28%
S&P 500 change since trade
+314.34%
Outperformance vs S&P 500
-229.06%

All John Boozman GILD trades

TradedTypeSizeReturnEst. profit
April 16, 2025SELL$102.16+29.92%
January 22, 2021SELL$54.94+141.61%
April 7, 2016BUY$67.13+97.72%+$3K
April 24, 2015BUY$71.64+85.28%+$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John Boozman & GILD trading FAQ

Is it legal for John Boozman to trade Gilead Sciences Inc (GILD) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Gilead Sciences Inc (GILD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John Boozman buy GILD?

John Boozman disclosed a purchase of $1,001 - $15,000 of Gilead Sciences Inc (GILD) on April 24, 2015, according to public STOCK Act filings.

How has GILD performed since John Boozman's trade?

Since John Boozman bought GILD on April 24, 2015, the stock is up +85.28%, versus +314.34% for the S&P 500 over the same period, an outperformance of -229.06%.

How many times has John Boozman traded GILD?

John Boozman has disclosed 4 GILD trades since 2015 (2 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional GILD trades?

Quantellect tracks every disclosed congressional trade in Gilead Sciences Inc (GILD) on the Gilead Sciences Inc congressional trading page, which aggregates filings across all members of Congress.

John Boozman's GILD tradesAll congressional filings for Gilead Sciences IncJohn Boozman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.